The covenant relaxation signals that Baxter's leverage is under pressure, likely from post-Hillrom debt and the Kidney Care divestiture. The debt buyback at a discount is a modest credit positive, reducing interest expense. Watch for the next 10-Q to see if leverage is actually below the 4.25x threshold; if it's tight, the stock may remain range-bound.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 19 $26.64entry
- T+1 · 3mo ago −0.86%α −0.02% · $26.41
- T+5 · 3mo ago −0.53%α −0.14% · $26.50
- T+20 · 2mo ago −13.59%α −11.64% · $23.02
- T+60 · 5d ago −3.38%α −1.83% · $25.74
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Baxter entered into Amendment No. 2 to its credit agreement, relaxing the net leverage ratio covenant for the next five quarters (maintaining it at 4.25x through Sep 2027 instead of stepping down) and removed a subsidiary borrower. Separately, the company completed a $600M cash tender offer for four series of senior notes, upsized from $500M, retiring ~$864M in principal at a discount. The covenant relief signals near-term financial strain, while the debt buyback at a discount is a modest credit positive, reducing interest expense and extending runway.
Key Facts
- Baxter amended its credit agreement to keep the maximum net leverage ratio at 4.25x through September 30, 2027, instead of stepping down to 4.00x in Sep 2027 and 3.75x thereafter.
- Baxter completed a $600M cash tender offer (upsized from $500M) for four series of senior notes, accepting $864M in principal at a discount.
- The tender offer accepted 100% of tendered 3.132% notes due 2051 ($422M), 3.500% notes due 2046 ($132M), and 4.500% notes due 2043 ($73M), plus 31.37% of tendered 2.539% notes due 2032 ($237M).
- Baxter World Trade SRL was removed as a borrower under the credit agreement.
- The company paid an early tender premium of $30 per $1,000 principal amount.
- No Final Settlement Date will occur; all notes tendered after Aug. 17, 2026 will be returned.
Financial Impact
Baxter retired ~$864M in principal for $600M in cash, a ~$264M discount. The covenant relaxation provides breathing room on leverage through Sep 2027.
Risk Factors
- Leverage may remain elevated, constraining financial flexibility.
- The company's dividend was recently cut to $0.01/share, indicating ongoing cash preservation.
- Forward-looking statements highlight risks from supply chain, inflation, and competition.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-057739 |
| Document: bax-20260818exhibit992.htm | 0001628280-26-057739 |
| Document: bax-20260818exhibit991.htm | 0001628280-26-057739 |
| Document: bax-20260818.htm | 0001628280-26-057739 |
| Document: 0001628280-26-057739-index-headers.html | 0001628280-26-057739 |
| Document: 0001628280-26-057739-index.html | 0001628280-26-057739 |
| Document: 0001628280-26-057739.txt | 0001628280-26-057739 |
Track record
15 reports on BAX
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +9.15% at T+5 after the Oct 29, 2026 report. 4 of 5 went positive at some point.
Filters
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $23.50 to $25.65 Now $25.54 +8.68% ▲ +9.15% +13.87% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $24.92 to $25.49 Now $25.54 +2.49% ▲ +2.29% +4.28% vs SPY
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $25.30 to $23.00 Now $25.54 +0.95% ▼ −9.09% −8.53% vs SPY
- Aug 19, 202612w ago 8-K Neutral 3/10 Entry $26.64 to $26.50 Now $25.54 −4.13% ▼ −0.53% −0.14% vs SPY
- Aug 18, 202612w ago 8-K Mixed 5/10 Viewing Entry $26.64 to $26.50 Now $25.54 −4.13% ▼ −0.53% −0.14% vs SPY
- Aug 12, 202613w ago Institutional Cluster Bullish 4/10 Entry $26.95 to $26.64 Now $25.54 −5.23% ▼ −1.15% −0.71% vs SPY
- Aug 4, 202614w ago 8-K Neutral 4/10 Entry $28.35 to $27.61 Now $25.54 −9.91% ▼ −2.61% −2.51% vs SPY
- Jul 30, 202615w ago 8-K Bullish 7/10 Entry $26.75 to $27.01 Now $25.54 −4.52% ▲ +0.97% −2.65% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 6/10 Entry $20.49 to $19.39 Now $25.54 −24.65% ▲ +5.37% +5.80% vs SPY
- May 8, 202627w ago 8-K Neutral 2/10 Entry $17.53 to $17.79 Now $25.54 +45.69% ▲ +1.48% +1.57% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers